)
)
Edge16 Oct 2026
Winner, Winner: The Chicken McNugget Story
How a 1940s breeding contest, a Cornell food scientist, and a hedge by Ray Dalio helped McDonald's turn the Chicken McNugget into a fast-food icon.
Vext Science
Vext Science (VEXT) investor relations material
Vext Science Q3 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q3 2026 earnings summary3 Nov, 2026
Executive summary
Record Q3 revenue of $14.899M, up 18% YoY and 23% QoQ; Ohio revenue rose 37% YoY to $10.9M.
Net loss was $4.884M and Adjusted EBITDA was $0.195M; operating cash flow reached $2.366M, double Q2.
Financial highlights
Gross profit was $3.0M; gross profit before fair value adjustments was $3.2M, or 21% of revenue, versus 44% in Q2.
Net loss was $4.884M versus $0.315M in Q2 and $2.628M in Q3 2025; 9M net loss narrowed to $6.1M from $7.4M.
Cash was $5.6M at quarter-end, up from $4.5M at June 30; inventory and biological assets declined $1.8M in Q3.
9M operating cash flow was $5.2M versus $6.4M of Adjusted EBITDA.
Outlook and guidance
Q4 includes costs from scaling back Phoenix and returning to normal operations after the Vapen hold and Jackson closure.
Columbus’s seventh Ohio dispensary is expected in Q1 2027; Amelia’s eighth is expected by end-Q3 2027, subject to regulatory approvals.
Combined Ohio store buildout costs are expected at $1.9M–$2.7M; the seventh store has a $2.4M construction loan commitment, with remaining costs funded from cash flow.
Priorities include growing Ohio, completing Arizona repositioning, strengthening the balance sheet, and funding growth primarily from internally generated cash.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Vext Science
- Ohio store growth and Arizona cost resets underpin expected cash flow expansion.VEXT
Corporate presentation - Margins and profitability improved as Ohio retail grew and Arizona shifted to a capital-light model.VEXTQ2 2026
- Ohio's 34% growth offset Arizona's decline, boosting margins and narrowing net loss.VEXTQ1 2026
- Retail-first strategy and Ohio expansion drive robust cash flow and long-term value.VEXTInvestor presentation
- FY 2025 revenue up 43% to $51.4M, led by Ohio retail growth and Arizona optimization.VEXTQ4 2025
- Q3 2024 revenue hit $9.0M with a 32% margin, fueled by Ohio adult-use and Arizona resilience.VEXTQ3 2024
- Q2 revenue was $8.4M as Ohio adult-use launch drives growth outlook despite margin pressure.VEXTQ2 2024
- Q1 2025 revenue up 38% to $11.6M, with strong cash flow and Ohio retail expansion.VEXTQ1 2025
- Ohio's adult use launch drove record Q4 growth, while Arizona outperformed a declining market.VEXTQ4 2024
Next Vext Science earnings date
Q4 202629 Apr, 2027
Vext Science
Next Vext Science earnings date
Q4 202629 Apr, 2027
AI chat
Ask anything. Verify everything.
Ask across every event and document from public companies. Each answer links back to the exact line in the transcript, slide or filing it came from.Learn moreFind what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.)
Trust every finding
50m+ first-party documents. Every output traceable to its source.Find what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.Trust every finding
50m+ first-party documents. Every output traceable to its source.Automations
Zero in on what matters
Define the prompt once. It runs the moment a company publishes or on a schedule you set. Outputs map to the exact signals you choose.Learn more)
Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.)
Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Live audio & transcripts
Be first
Join any earnings call live in one click, with no manual registration. Follow the transcript as it happens and jump straight to the moments that matter.Learn more)
Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.)
Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Quartr MCP connects your AI environment to 17K+ public companies
Pull live transcripts, filings, and slides into Claude or Codex via MCP. Combine Quartr's global IR data with any other dataset. Run agentic research and monitoring.
Included with Quartr Pro at no extra cost.Learn more
Quartr's AI stands out because it only pulls clean, first-party data from public companies. In investing, that's everything.
Jamie Ross
Investment Manager, GAM Investments
GAM
GAM
Research that used to take hours now takes seconds with Quartr Pro. Tracking shifts in tone or extracting tables, it's as simple as typing a query.
Tom O'Hara
Investment Director
Ciena
Ciena
Before Quartr we spent hours manually compiling insights through the peer earnings cycle. Now, these tasks are done faster, with greater precision.
Gregg Lampf
VP of Investor Relations
Protean
Protean
Being able to ask specific questions across years of transcripts and reports and instantly get verified answers is a game-changer.
Pontus Dackmo
CEO & Investment Manager
)
)
Frequently asked questions
Vext Science Inc. is a U.S.-based cannabis company engaged in the cultivation, production, and sale of cannabis products. The company operates in both the medical and recreational markets, offering a range of products including flower, edibles, and extracts. Vext Science also provides manufacturing and distribution services for third-party cannabis brands. Through its Vapen brand, the company focuses on delivering high-quality, consistent cannabis products to consumers, primarily operating in the state of Arizona with plans for expansion into other markets. The company is headquartered in Phoenix, Arizona, and its shares are listed on the Canadian Securities Exchange.